Abstract
The selective inhibition of coagulation factor Xa has emerged as an attractive strategy for the discovery of novel antithrombotic agents. Here we describe highly potent benzamidine factor Xa inhibitors based on a vicinally-substituted heterocyclic core.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have